Evaluation of the quality of non-cultured autologous skin cell suspension after cryopreservation
Main Article Content
Abstract
Autologous non-cultured skin cell therapy has gradually become a potential approach for the treatment of wounds and extensive deep burns [1, 2]. The use of non-cultured skin cell suspensions has been proven to positively influence the wound healing process. Standardizing the cryopreservation procedure for these suspensions holds significant scientific and clinical value.
Objective: To evaluate cell quality after 4 weeks of cryopreservation at different DMSO concentrations using blue Trypan staining and cell culture methods.
Materials and methods: Ten thin split-thickness skin samples (0.25 mm) were collected from donor sites during autologous skin graft surgery. The isolated cell suspensions were cryopreserved at -800C using different DMSO concentrations (9%, 10%, 11%). After thawing, cell viability was assessed using blue Trypan staining, and cultured to evaluate their ability of the cells to attach and proliferate.
Results: The mean post-isolation cell viability was above 80%, with the highest reaching 92.1%. A DMSO concentration of 10% (C2) was identified as optimal for cryopreservation. After 4 weeks of storage, cell viability slightly decreased, but the cells remained viable, adherent, and capable of proliferation in culture.
Conclusion: The study demonstrated that non-cultured autologous skin cell suspensions maintained high viability after 4 weeks of cryopreservation. Cells thawed and cultured in defined media remained viable after 6 days, with 10% DMSO identified as the optimal cryoprotectant concentration.
Article Details
Keywords
Skin cell suspension, DMSO, cryopreservation
References
2. Zhao, H., et al., Autologous epidermal cell suspension: a promising treatment for chronic wounds. Journal of Tissue Viability, 2016. 25(1): p. 50-56.
3. Sen, C.K., et al., Human skin wounds: a major and snowballing threat to public health and the economy. Wound repair and regeneration, 2009. 17(6): p. 763-771.
4. Dinh VH, Nguyen TH, Nguyen PT, Ngo NH. Đánh giá khả năng phân lập tế bào da của enzyme Dispase II và Trypsin và định hướng sử dụng enzyme trong chế tạo hỗn dịch tế bào da để điều trị vết thương và vết bỏng. Tạp chí Y học Việt Nam. 2014.
5. Strober, W., Trypan blue exclusion test of cell viability. Current protocols in immunology, 1997. 21(1): p. A. 3B. 1-A. 3B. 2.
6. Freshney, R.I., Other Epithelial Cells. Culture of Epithelial Cells, 2002: p. 401-436.
7. Atiyeh, B.S., et al., Effect of silver on burn wound infection control and healing: review of the literature. burns, 2007. 33(2): p. 139-148.
8. Meneghel, J., P. Kilbride, and G.J. Morris, Cryopreservation as a key element in the successful delivery of cell-based therapies: A review. Frontiers in Medicine, 2020. 7: p. 592242.
9. Niebergall-Roth, E. and M.A. Kluth, Dimethyl sulfoxide in cryopreserved mesenchymal stromal cell therapy products: is there a safety risk to patients? Journal of Translational Medicine, 2025. 23(1): p. 932.
10. Flahaut, M., et al., Reassessing long-term cryopreservation strategies for improved quality, safety, and clinical use of allogeneic dermal progenitor cells. Journal of Investigative Dermatology, 2024. 144(10): p. 2125-2135.